pancreatic cancer stage iv
Showing 1 - 15 of 15
Pancreatic Cancer Stage IV, Chemo-induced Nausea and Vomiting Trial (Thalidomide, Nab paclitaxel, Gemcitabine)
Not yet recruiting
- Pancreatic Cancer Stage IV
- Chemotherapy-induced Nausea and Vomiting
- Thalidomide
- +2 more
- (no location specified)
Aug 24, 2023
Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +12 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 30, 2022
Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- +14 more
- Melphalan
- +5 more
-
Boston, Massachusetts
- +1 more
Dec 6, 2022
Pancreatic Cancer Stage IV Trial in United States (CBP501 (16), CBP501 (25), Cisplatin)
Active, not recruiting
- Pancreatic Cancer Stage IV
- CBP501 (16)
- +3 more
-
Tucson, Arizona
- +19 more
Aug 16, 2022
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV, Pancreatic Cancer Non-resectable Trial in Oxford (Focused
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
- Focused Ultrasound
- +2 more
-
Oxford, United KingdomOxford University Hospitals NHS Trust
Feb 22, 2022
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV Trial (SBP-101, Nab-paclitaxel,
Not yet recruiting
- Pancreatic Cancer Metastatic
- +2 more
- SBP-101
- +3 more
- (no location specified)
Feb 21, 2022
Melanoma Stage IV, Sarcoma, Squamous Cell Carcinoma Trial in Berlin (CTC isolation by HSP70)
Recruiting
- Melanoma Stage IV
- +5 more
- CTC isolation by HSP70
-
Berlin, GermanyKlinik für Radioonkologie und Strahlentherapie
May 12, 2021
Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV Trial in Japan (TBI-1401(HF10), Gemcitabine, Nab-paclitaxel)
Active, not recruiting
- Pancreatic Cancer Stage III
- Pancreatic Cancer Stage IV
- TBI-1401(HF10)
- +3 more
-
Nagoya, Aichi, Japan
- +7 more
Mar 31, 2021
Pancreatic Cancer Stage IV, Pancreatic Cancer Metastatic Trial (Camrelizumab, Paclitaxel(Albumin Bound) and Gemcitabine,
Not yet recruiting
- Pancreatic Cancer Stage IV
- Pancreatic Cancer Metastatic
- Camrelizumab
- +2 more
- (no location specified)
Dec 15, 2020
MicroRNA in Diagnosis, Prognosis and Response to Treatment in
Recruiting
- Pancreatic Cancer Stage III
- +3 more
- Blood draw
-
Norwalk, ConnecticutNuvance Health
Oct 5, 2020
Pancreas Cancer, Pancreatic Cancer, Pancreatic Cancer Stage IV Trial in Paris, London (IMM-101)
No longer available
- Pancreas Cancer
- +3 more
- IMM-101
-
Paris, France
- +1 more
Aug 12, 2020
Pancreatic Cancer Stage IV Trial in La Jolla (Gemcitabine, Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Cabiralizumab)
Suspended
- Pancreatic Cancer Stage IV
- Gemcitabine
- +2 more
-
La Jolla, CaliforniaUCSD Moores Cancer Center
May 5, 2020
Pancreatic Cancer Stage IV Trial in Shanghai (Biological: SHR-1210 Drug: Gemcitabine Drug:Paclitaxel-albumin)
Unknown status
- Pancreatic Cancer Stage IV
- Biological: SHR-1210 Drug: Gemcitabine Drug:Paclitaxel-albumin
-
Shanghai, Shanghai, ChinaRenJiH
Nov 27, 2019
Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV Trial in Tianjin (Gemcitabine, GPBSC)
Unknown status
- Pancreatic Cancer Stage III
- Pancreatic Cancer Stage IV
- Gemcitabine
- GPBSC
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jul 28, 2017
Pancreatic Cancer Stage IV Trial in Beijing (Intraoperative radiotherapy (IORT), Sequential chemo, Three dimensional conformal
Unknown status
- Pancreatic Cancer Stage IV
- Intraoperative radiotherapy (IORT)
- +3 more
-
Beijing, Beijing, ChinaCancerIHCAMS
Nov 30, 2016